DA32 Life Science Tech Acquisition Corp. (NASDAQ:DALS – Get Rating) was the recipient of a large growth in short interest during the month of November. As of November 30th, there was short interest totalling 44,800 shares, a growth of 16.7% from the November 15th total of 38,400 shares. Based on an average daily volume of 37,600 shares, the days-to-cover ratio is presently 1.2 days. Currently, 0.3% of the company's shares are short sold.
Institutional Trading of DA32 Life Science Tech Acquisition
Several institutional investors and hedge funds have recently added to or reduced their stakes in DALS. Saba Capital Management L.P. bought a new stake in DA32 Life Science Tech Acquisition during the 1st quarter worth about $10,883,000. Sculptor Capital LP raised its holdings in DA32 Life Science Tech Acquisition by 165.6% during the 1st quarter. Sculptor Capital LP now owns 763,628 shares of the company's stock worth $7,419,000 after purchasing an additional 476,127 shares during the last quarter. Mangrove Partners raised its holdings in DA32 Life Science Tech Acquisition by 513.4% during the 3rd quarter. Mangrove Partners now owns 450,000 shares of the company's stock worth $4,379,000 after purchasing an additional 376,644 shares during the last quarter. RP Investment Advisors LP raised its holdings in DA32 Life Science Tech Acquisition by 653.1% during the 1st quarter. RP Investment Advisors LP now owns 408,856 shares of the company's stock worth $3,972,000 after purchasing an additional 354,569 shares during the last quarter. Finally, Cubist Systematic Strategies LLC grew its position in shares of DA32 Life Science Tech Acquisition by 216.1% during the 3rd quarter. Cubist Systematic Strategies LLC now owns 445,410 shares of the company's stock worth $4,334,000 after buying an additional 304,492 shares during the period. 60.43% of the stock is owned by institutional investors.
Get DA32 Life Science Tech Acquisition alerts:DA32 Life Science Tech Acquisition Stock Performance
NASDAQ:DALS remained flat at $9.89 on Friday. The company's stock had a trading volume of 2 shares, compared to its average volume of 84,956. DA32 Life Science Tech Acquisition has a 12-month low of $9.58 and a 12-month high of $10.57. The business has a 50 day moving average of $9.82 and a 200-day moving average of $9.75.
About DA32 Life Science Tech Acquisition
(Get Rating)DA32 Life Science Tech Acquisition Corp. does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. The company intends to identify business combination targets in the biotechnology and life science infrastructure sectors.
See Also
- Get a free copy of the StockNews.com research report on DA32 Life Science Tech Acquisition (DALS)
- Which Two Bluechip Tech Companies Have Raised Their Guidance?
- Should You Worry About Elon Musk Selling His Tesla Shares?
- Can Tractor Supply Stock Surge Past Cup-With-Handle Buy Point?
- This is no Time to Buy Lennar but the Time is Coming
- Game-Changing News For Mullen Automotive
Receive News & Ratings for DA32 Life Science Tech Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DA32 Life Science Tech Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.